Skip to content

Intercept 3001-2869Recalls & reported problems

Orasure Technologies, Inc. · Intercept Collection Device · Class 2

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00608337000078), received between Nov 21, 2016 and Sep 17, 2020 — classified as 2 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2

Patient problems

  • Headache1
  • Reaction1
  • Swelling1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjurySep 17, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT DONOR REPORTED AN ALLERGIC REACTION AFTER HAVING THE INTERCEPT TEST ADMINISTERED. THE DONOR REPORTED TO HAVE RECEIVED THE INTERCEPT TEST AROUND APPROXIMATELY 10:45-11:00 AM AND LEFT THE PHYSICAL EXAMINATION AROUND 11:49-11:56 AM. AT THIS POINT IN TIME SHE NOTICED THE SWELLING THAT WAS OCCURRING OF HER LIPS ON THE SIDE OF THE MOUTH WHERE THE TEST WAS ADMINISTERED. THE DONOR TOOK A BENADRYL LATER THAT AFTERNOON (NO TIME GIVEN) BECAUSE THE SWELLING HAD NOT SUBSIDED AT THAT POINT IN TIME. THE DONOR REPORTED AT 11:00 PM THE SWELLING HAD GOT WORSE AND DECIDED TO GO TO THE EMERGENCY ROOM FOR TREATMENT. THE PATIENT WAS IN THE ER UNTIL 12:35 PM WHICH WAS APPROXIMATELY 12 HOURS AFTER THE TEST WAS ADMINISTERED. THE ER ADMINISTERED A STERIOD AND PRILOSEC TO COAT THE DONORS STOMACH AND WROTE OUT A PRESCRIPTION FOR AN EPI PEN AND BENADRYL FOR THE ALLERGIC REACTION. THE PATIENT DONOR TOOK THE PRESCRIBED BENADRYL AND BY 1:00 PM THE FOLLOWING DAY THE SWELLING HAD SUBSIDED. THE EPI PEN PRESCRIPTION WAS GIVEN ONLY AS A PRECAUTIONARY MEASURE BY THE ER.

    Patient problems: Reaction; Swelling

    MAUDE report 10546883 ↗
  • InjuryNov 21, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AN UNKNOWN FEMALE REPORTED THAT AFTER USING THE INTERCEPT ORAL FLUID COLLECTION DEVICE SHE DEVELOPED AN AFTER TASTE WHICH LED TO AN ONSET OF A MIGRAINE HEADACHE. SHE WAS EVALUATED BY HER EMPLOYER AND THEN TRANSPORTED TO THE EMERGENCY ROOM FOR EVALUATION.

    Patient problems: Headache

    MAUDE report 6116211 ↗

Other Oral Fluid Drugs Of Abuse And Alcohol Test Specimen Collection Device devices

All Oral Fluid Drugs Of Abuse And Alcohol Test Specimen Collection Device devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page